BRAF and melanoma: Thus far, INDRA and the automated extraction of molecular mechanisms have been used in modeling p53 dynamics in response to DNA damage, adaptive drug resistance in BRAF-V600E-mutant melanomas, and the RAS signaling pathway [27].